Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Nakashima

Showing results (111-120 of 118) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 118 results.
International Journal of Cancer|December 30, 2003
Identification of bladder cancer antigens recognized by IgG antibodies of a patient with metastatic bladder cancerKeiichi Ito, Tomonobu Fujita, Masanori Akada, et al.
Journal of Cardiac Failure|May 12, 2024
Validation of a Supportive and Palliative Care Indicator Tool Among Patients Hospitalized Due to Heart FailureYasuhiro Hamatani, Kanako Teramoto, Yurika Ikeyama-Hideshima, et al.
Medical Oncology (Northwood, London, England)|June 11, 2014
Optimal timing of hormonal therapy for prostate-specific antigen recurrence after radical prostatectomyKazuhiro Matsumoto, Ryuichi Mizuno, Nobuyuki Tanaka, et al.
Hematological Oncology|January 11, 2020
Treatment with mogamulizumab or lenalidomide for relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation: The Nagasaki transplant group experienceHikaru Sakamoto, Hidehiro Itonaga, Yasushi Sawayama, et al.
British Journal of Haematology|January 26, 2026
Improvement in survival of patients with higher risk but not lower risk myelodysplastic syndromes over 20 years: A retrospective study from Nagasaki, JapanTakafumi Furumoto, Koji Ando, Eo Toriyama, et al.
Internal Medicine (Tokyo, Japan)|February 22, 2021
Efficacy and Cardiovascular Adverse Events of Long-term Treatment with Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: A Report from the Nagasaki CML Study GroupMasahiko Chiwata, Hidehiro Itonaga, Shinya Sato, et al.
Internal Medicine (Tokyo, Japan)|July 9, 2025
Efficacy of Azacitidine Plus Venetoclax in Acute Myeloid Leukemia Transformed from Myelodysplastic Syndrome after Failure of Azacitidine MonotherapyTakafumi Furumoto, Koji Ando, Eo Toriyama, et al.
Leukemia Research|November 23, 2013
Molecular analysis of the BCR-ABL1 kinase domain in chronic-phase chronic myelogenous leukemia treated with tyrosine kinase inhibitors in practice: study by the Nagasaki CML Study GroupHidehiro Itonaga, Hideki Tsushima, Daisuke Imanishi, et al.
Pageof 12

Showing results (111-120 of 118) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 118 results.
International Journal of Cancer|December 30, 2003
Identification of bladder cancer antigens recognized by IgG antibodies of a patient with metastatic bladder cancerKeiichi Ito, Tomonobu Fujita, Masanori Akada, et al.
Journal of Cardiac Failure|May 12, 2024
Validation of a Supportive and Palliative Care Indicator Tool Among Patients Hospitalized Due to Heart FailureYasuhiro Hamatani, Kanako Teramoto, Yurika Ikeyama-Hideshima, et al.
Medical Oncology (Northwood, London, England)|June 11, 2014
Optimal timing of hormonal therapy for prostate-specific antigen recurrence after radical prostatectomyKazuhiro Matsumoto, Ryuichi Mizuno, Nobuyuki Tanaka, et al.
Hematological Oncology|January 11, 2020
Treatment with mogamulizumab or lenalidomide for relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation: The Nagasaki transplant group experienceHikaru Sakamoto, Hidehiro Itonaga, Yasushi Sawayama, et al.
British Journal of Haematology|January 26, 2026
Improvement in survival of patients with higher risk but not lower risk myelodysplastic syndromes over 20 years: A retrospective study from Nagasaki, JapanTakafumi Furumoto, Koji Ando, Eo Toriyama, et al.
Internal Medicine (Tokyo, Japan)|February 22, 2021
Efficacy and Cardiovascular Adverse Events of Long-term Treatment with Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: A Report from the Nagasaki CML Study GroupMasahiko Chiwata, Hidehiro Itonaga, Shinya Sato, et al.
Internal Medicine (Tokyo, Japan)|July 9, 2025
Efficacy of Azacitidine Plus Venetoclax in Acute Myeloid Leukemia Transformed from Myelodysplastic Syndrome after Failure of Azacitidine MonotherapyTakafumi Furumoto, Koji Ando, Eo Toriyama, et al.
Leukemia Research|November 23, 2013
Molecular analysis of the BCR-ABL1 kinase domain in chronic-phase chronic myelogenous leukemia treated with tyrosine kinase inhibitors in practice: study by the Nagasaki CML Study GroupHidehiro Itonaga, Hideki Tsushima, Daisuke Imanishi, et al.
Pageof 12